Somatostatin Analogs Market Research, Size, Trends, Revenue Share Analysis, Forecast Till 2030
Somatostatin Analogs Market is expected to hold a value of about USD 8,640 Million and it is projected to grow at a CAGR of 6.8% during the forecast period. Somatostatin analogs drugs stop the excessive hormone secretion in the body. Neuroendocrine Tumors (NETs) and Acromegaly, a rare hormonal disorder, are the most common indications treated with somatostatin analogs. The...
0 Comments 0 Shares 1580 Views 0 Reviews